Screener
Veracyte VCYT Amortization of acquired technology
Amortization of acquired technology at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Veracyte in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSoldAmortization.
The source filing: Veracyte’s 10-Q, filed May 6, 2026.
- Filed
- May 6, 2026, 8:07 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001384101-26-000031
| Line item | Three Months Ended March 31, 2026 | 2025 |
|---|---|---|
| Cost of testing revenue | 33,306 | 28,260 |
| Cost of product revenue | 1,891 | 1,422 |
| Cost of biopharmaceutical and other revenue | 8 | 2,698 |
| Intangible asset amortization - cost of revenue | 2,707 | 2,585 |
| Total cost of revenue | 37,912 | 34,965 |
| Gross profit | 101,159 | 79,508 |
| Operating expenses: | ||
| Research and development | 27,098 | 17,720 |
Item 1. Condensed Consolidated Financial Statements (Unaudited)
FAQ
- What is Veracyte's amortization of acquired technology?
- Veracyte (VCYT) reported amortization of acquired technology of $2.71M in Q1 2026.
- How has Veracyte's amortization of acquired technology changed year-over-year?
- Veracyte's amortization of acquired technology increased by 4.7% year-over-year, from $2.59M to $2.71M.
- What is the long-term trend for Veracyte's amortization of acquired technology?
- Over 3 years (2022 to 2025), Veracyte's amortization of acquired technology has grown at a -17.9% compound annual growth rate (CAGR), from $19.27M to $10.67M.
- What does amortization of acquired technology mean?
- This represents the non-cash expense related to the systematic allocation of the cost of acquired intangible assets, such as patents or proprietary technology, over their estimated useful lives. It reflects the consumption of economic value from previously acquired intellectual property used in the production of goods or services. Investors monitor this to distinguish between operational production costs and the accounting recognition of historical acquisition investments.
Ask your AI about Veracyte's amortization of acquired technology.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude